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Sistemas Complejos, Zaragoza, SpainABSTRACT Infection by human immunodeficiency virus (HIV) depends on the function, in virion morphogenesis and other
stages of the viral cycle, of a highly conserved structural element, the major homology region (MHR), within the carboxyterminal
domain (CTD) of the capsid protein. In a modified CTD dimer, MHR is swapped between monomers. While no evidence for MHR
swapping has been provided by structural models of retroviral capsids, it is unknown whether it may occur transiently along the
virus assembly pathway. Whatever the case, the MHR-swapped dimer does provide a novel target for the development of anti-
HIV drugs based on the concept of trapping a nonnative capsid protein conformation. We have carried out a thermodynamic and
kinetic characterization of the domain-swapped CTD dimer in solution. The analysis includes a dissection of the role of
conserved MHR residues and other amino acids at the dimerization interface in CTD folding, stability, and dimerization by
domain swapping. The results revealed some energetic hotspots at the domain-swapped interface. In addition, many MHR res-
idues that are not in the protein hydrophobic core were nevertheless found to be critical for folding and stability of the CTDmono-
mer, which may dramatically slow down the swapping reaction. Conservation of MHR residues in retroviruses did not correlate
with their contribution to domain swapping, but it did correlate with their importance for stable CTD folding. Because folding is
required for capsid protein function, this remarkable MHR-mediated conformational stabilization of CTD may help to explain the
functional roles of MHR not only during immature capsid assembly but in other processes associated with retrovirus infection.
This energetic dissection of the dimerization interface in MHR-swapped CTD may also facilitate the design of anti-HIV com-
pounds that inhibit capsid assembly by conformational trapping of swapped CTD dimers.INTRODUCTIONDuring human immunodeficiency virus type 1 (HIV-1)
morphogenesis (1–3), the viral Gag polyprotein (containing
the capsid protein CA) assembles into a spherical capsid,
which is enclosed in the immature virion. Gag is later
cleaved, and free CA reassembles into a cone-shaped capsid
within the mature, infectious virion.
The folded CA polypeptide is made of two domains
(Fig. 1). The N-terminal domain (NTD) includes seven a-
helices (helices 1–7) (4). The C-terminal domain (CTD)
contains a 310-helix, an extended strand, and four a-helices
(helices 8–11) (5) (Fig. 1 a).
Fitting the atomic structures of CA oligomers in cryo-
electron microscopy, crystallography, or tomography den-
sity maps of authentic capsids or capsidlike particles yielded
pseudoatomic models of immature (6–8) and mature (9–14)
capsids. The models revealed several functionally relevant
interfaces involving interactions between CA subunits (1–
3,15,16). These findings are proving extremely helpful inSubmitted May 9, 2014, and accepted for publication November 24, 2014.
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0006-3495/15/01/0338/12 $2.00the identification and characterization of capsid-assembly
inhibitors that could lead to novel anti-HIV drugs (17–20).
A 20-residue structural element within the CTD, termed
the major homology region (MHR) (5), exhibits a most
conserved sequence, and this extreme conservation in an
otherwise highly variable virus has long intrigued re-
searchers. This motif is formed by an extended strand, a
b-turn, and helix 8 (Fig. 1 b), and it contains conserved res-
idues involved in a network of hydrogen bonds and hydro-
phobic contacts (5), which could stabilize the folded
conformation (21). The MHR is critical to HIV-1 infection
and, remarkably, has been found to be functionally involved
in several different stages of the retroviral cycle, including
immature capsid assembly (see, e.g., (22–29)).
In dimeric CA and CTD (both in solution and in most
crystal forms) and in the mature HIV-1 capsid, the CTD
monomers associate through the parallel packing of helix
9, which leads to a side-by-side dimer (5) (Fig. 1 a, upper).
However, a structural homolog of retroviral CTD (a
mammalian SCAN domain) forms a domain-swapped dimer
in solution (30,31), and a mutant CTD (D177-CTD) from
HIV-1, in which alanine 177 was deleted, was crystallized
as a domain-swapped dimer by Ivanov et al. (32) (Fig. 1
a, lower). Interestingly, the exchanged part corresponds to
the MHR motif, with several of its conserved residues beinghttp://dx.doi.org/10.1016/j.bpj.2014.11.3472
FIGURE 1 Molecular structures of CTD and D177-CTD. a-helices (H8–H11) are labeled. (a) Ribbon models of the crystal structures of the CTD side-by-
side dimer (5) (Protein Data Bank (PDB) code 1A43) (upper) and the D177-CTD domain-swapped dimer (32) (PDB code 2ONT) (lower). W184 residues are
represented as blue spacefilling models. The positions of A177 in CTD and its deletion in D177-CTD are indicated. (b) Ribbon model of a CTD monomer in
the side-by-side dimer, with the MHR depicted in orange. Stick models are used to represent the side chains of W184, six conserved MHR residues that
participate in domain swapping and were subjected to mutational analyses in this study (R154, Q155, Y164, V165, and F168 (black labels)), and three others
(G156, E159, and R167 (red labels)) that do not participate in domain swapping and were subjected to mutation in a previous study (21). (c) Ribbon model of
the structure of the D177-CTD domain-swapped dimer, in which interfacial MHR and non-MHR residues subjected to mutational analysis in this study are
represented as stick models. Residues at the primary or secondary dimerization interfaces are labeled in blue and orange, respectively. Models were drawn
using Pymol (71).
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MHR has a functional role in immature HIV-1 capsid as-
sembly, Ivanov et al. suggested that MHR conservation
could be due to its involvement in CTD dimerization by
domain swapping during immature HIV assembly (32).
A recent, detailed pseudoatomic model (8) does not sup-
port the existence of the domain-swappedCTDconformation
in the immature retroviral capsid. However, domain swap-
ping, as well as other alternativemodes of tertiary and quater-
nary organization detected in the conformationally dynamic
CTD in oligomers or viral-like particles in vitro (e.g., (9,33–
39)), could transiently occur along the still poorly known
HIV-1 capsid assembly pathways (40–46).
Irrespective of whether CTD dimerization by domain
swapping is a participant in HIV-1 morphogenesis (an unre-
solved question to date), it is a fact that under certain condi-
tions (physiological or not), CTD can dimerize by swapping
(32). Thus, a thorough biophysical characterization of this
reaction could contribute to the development of an antiviral
compound that could substantially stabilize (trap) this alter-
native CTD conformation. If the swapped dimer occurs on-
pathway during HIV assembly, stabilizing the swapped
intermediate could stop the reaction halfway. If the swapped
dimer does not participate in virus assembly, converting
CTD to this nonphysiological form would deplete the as-
sembly reaction of the necessary capsid building blocks.
Either way, HIV infection could be impaired. Experimental
compounds capable of trapping CTD (within full-length CA
or Gag) in other nonproductive conformations have already
been identified (18,34,36).
Domain swapping has been observed in a significant
and growing number of proteins ((47); for review, seeRousseau et al. (48,49)). In this process, two identical
monomers exchange a part (called ‘‘domain’’) of their
structure to form an intertwined dimer or other oligomer.
The structure of the monomer is basically unchanged in
the domain-swapped dimer, except in the linker that con-
nects the exchanged part with the rest of the polypeptide.
Thus, the exchanged part makes intermolecular interac-
tions (the primary interface) in the domain-swapped dimer
that essentially correspond to the intramolecular interac-
tions it makes in the isolated monomer. Additional interac-
tions between monomers in the domain-swapped dimer
may occur (creating a secondary interface) (49). The bio-
logical significance of domain swapping is still uncertain
in many cases, but in some proteins it may promote mis-
folding or regulate function (48,49) or stabilize viral parti-
cles (50). Studies on the thermodynamics and kinetics of a
few domain-swapped cellular proteins provide important
insights into this process and its biological roles (e.g.,
(48,49,51–59)).
In this study, we have carried out a thermodynamic and
kinetic characterization of the domain-swapped D177-
CTD dimer in solution with a twofold aim: 1) to provide
biophysical evidence for or against domain swapping as a
possible participant in HIV assembly and the main cause
of MHR conservation and, eventually, to find alternative
causes for such conservation; and 2) to characterize this
alternative CTD dimerization, to provide further insights
into protein domain swapping in general, and to facilitate
the development of a novel HIV assembly inhibitor based
on conformational trapping. The implications of the results
for HIV biology and the design of anti-HIV drugs are
discussed.Biophysical Journal 108(2) 338–349
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Recombinant plasmids and site-directed
mutagenesis
Plasmid pWISP98-85 containing the CA coding sequence from the pNL4.3
strain of HIV-1 was obtained through the AIDS Research and Reference
Reagent Program, Division of AIDS, National Institute of Allergy and In-
fectious Diseases, National Institutes of Health (60). The triplet coding
for A177 in CAwas deleted using the Quik Change Site-Directed Mutagen-
esis kit (Stratagene, La Jolla, CA) to obtain plasmid pWISP98-85D177. The
CTD-coding sequence with Ala177 deleted (D177-CTD) (32) in that
plasmid was subcloned in plasmid pGEX-2T (GE Healthcare, Little Chal-
font, United Kingdom) to obtain pGEX-2T-CTDD177. The construction of
plasmid pET21-CTD containing the coding sequence for nonmutated CTD
from strain BH10 of HIV-1 has been previously described (21). Deletion of
the A177 codon in the CTD (BH10) and introduction of missense mutations
in the CTD or in D177-CTD were performed on pET21-CTD or pGEX-2T-
CTDD177 as appropriate using the procedures indicated above. The muta-
tions were confirmed by sequencing the entire CTD coding region.Protein expression and purification
CTD and mutants that do not carry the D177 deletion were purified as previ-
ously described (21). D177-CTD and mutants were expressed as fusion pro-
teins with glutathione-S-transferase (GST) (32) and purified by affinity
chromatographyusingGSTrapHP(GEHealthcare), following the instructions
of the GST Gene Fusion System (GE Healthcare). GST was subsequently
cleavedoff by thrombin, andGSTand thrombinwere eliminatedusingGSTrap
HP followed by HiTrap Benzamidine FF (GE Healthcare). Purified proteins
weremaintained in phosphate-buffered saline (PBS) with 5mMdithiothreitol
(DTT) at 4Cuntil dimerization equilibriumwas reached.Theprotein solution
was then applied to a size-exclusion chromatography (SEC) Superdex 75 col-
umn (GEHealthcare). Fractions containingmonomer or dimer forms ofD177-
CTD were separately pooled, found free of contaminants as determined by
sodiumdodecyl sulfate-polyacrylamide gel electrophoresis, and stored at 4C.Fluorescence and circular dichroism
spectroscopy
Fluorescence and circular dichroism (CD) analyses were done as previously
described (21). The Trp fluorescence spectrum of D177-CTD monomer or
dimer was obtained at 25C; the effect of guanidinium hydrochloride
(GdmHCl) was determined. The recorded far-UV CD spectra at 25C
were the averages of four scans between 190 and 250 nm obtained at a
rate of 50 nm/min, a response time of 2 s, and a bandwidth of 1 nm.Denaturation equilibrium analysis
Thermodynamic analysis of CTD unfolding was carried out by far-UV CD as
described (21). The program KaleidaGraph (Synergy Software) was used for
fitting all data obtained in thermodynamic and kinetic experiments. Chemical
denaturation analysis ofD177-CTD (pure monomer or dimer) was carried out
bymeasuring the ellipticity at 222 nm of samples kept at 25C and containing
20mMprotein (monomerconcentration), unless otherwise specified, in25mM
sodium phosphate buffer, pH 7.4, with different GdmHCl concentrations.
The data obtained in chemical denaturation equilibrium experiments
were fitted to a unimolecular transition between native and denatured
monomer as previously described (21). The thermodynamic parameters ob-
tained were the concentration of denaturant at which 50% of the protein
molecules are denatured ([D]50%), the variation in free energy with dena-
turant concentration (m), and the variation in free energy of the reaction
extrapolated to absence of denaturant (DGu
H2O).Biophysical Journal 108(2) 338–349Thermal denaturation analyses of D177-CTD, CTD, and mutants were
carried out by monitoring the ellipticity at 222 nm of equivalent samples
(without GdmHCl) subjected to a 4C to 90C thermal gradient (at a rate
of 0.5C/min). The data obtained in thermal denaturation equilibrium ex-
periments were fitted to a unimolecular transition between native and dena-
tured monomer by direct nonlinear fitting of the experimental ellipticity
values, q, in the equation (21)
q ¼ ½ðqn0 þ mnTÞ þ ðqu0 þ muTÞ
 expð  DGu=RTÞ=½1þ expð  DGu=RTÞ;
(1)
whereDGu ¼ DHTmu ð1 T=TmÞ þ DCp½T  Tm  T lnðT=TmÞ
(2)
and q is the experimental ellipticity obtained at a temperature T, R is the
ideal gas constant, qn0 and qu0 are the ellipticity values, respectively, corre-sponding to the native (n) or denatured (u) states extrapolated to T ¼ 0, mn
and mu are the slopes of the baselines respectively preceding or following
the transition region, Tm is the transition temperature, and DHu
Tm is
the variation in enthalpy of unfolding at the Tm. A DCp value of
1200 cal/mol, in the normal range of heat capacity for protein denaturation
processes (21), was assumed to fit the equation. As expected, changing this
value to the lower or upper limit of the range determined for protein dena-
turation did not significantly change the Tm or DHu
Tm values. Direct fitting
yielded the values of qn0, qu0, mn, mu, Tm, and DHu
Tm.Dimerization equilibrium analysis
The D177-CTD monomer-dimer equilibrium was analyzed by SEC (55).
Purified D177-CTD and mutants were maintained over the course of several
weeks at high concentration (between 300 mM and 1 mM) until equilibrium
was reached (as revealed by no significant further change in the dimer-to-
monomer ratio). A volume of 100 mL of a protein solution at specified con-
centrations in PBS, pH 7.4, supplemented with 5 mM DTTwas applied to a
calibrated Superdex 75 analytical column (GE Healthcare) at 25C, and the
absorbance at 280 nm was monitored. The fractions of dimer and monomer
were determined by measuring the areas of the peaks in the chromatogram
and their concentrations were obtained at each total protein concentration
tested. The equilibrium dissociation constant, Kd, was then directly calcu-
lated from the monomer (M) and dimer (D) concentrations (55):
Kd ¼ ½M2
½D: (3)
Kinetic analyses of D177-CTD dimerization and
dissociation
The association and dissociation kinetics of D177-CTD were followed by
analytical SEC at 25C. To determine the association kinetics parameters,
the monomeric form separated from the dimeric form by SEC was imme-
diately concentrated to 300 mM, and 100 mL aliquots taken at different
times after the dimer was isolated were applied to a Superdex 75 analytical
column immediately after they were taken. The fractions of dimeric and
monomeric forms were determined as described above. The fraction of
dimer as a function of time was fitted to the equation that describes a sec-
ond-order reaction from monomer to dimer:
DðtÞ ¼ Df  ðA=ðCt kast þ 1ÞÞ; (4)
where D(t) is the fraction of dimer at time t, Df is the fraction of dimer at
infinite time, A is the amplitude (the difference between the initial and final
values of D), and kas is the association rate constant.
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separated from the monomeric species by SEC was diluted to 20 mM,
and 100 mL aliquots taken at different times after the dimer was isolated
were applied to a Superdex 75 column. The fractions of dimer and mono-
mer were then determined as indicated above. The fraction of dimer as a
function of time could be fitted, as supported by residual analysis, to an
equation that describes a sum of two first-order exponential decay
reactions:
DðtÞ ¼ Df þ A1 expðkdis1tÞ þ A2 expðkdis2tÞ; (5)
where D(t) is the fraction of dimer at time t, Df is the fraction of dimer at
infinite time, A1 and A2 are the amplitudes of the two processes considered,
and kdis1 and kdis2 are the corresponding dissociation rate constants.Kinetic analyses of canonical CTD dimerization
and dissociation
The fast association and dissociation kinetics of the canonical CTD dimer
were analyzed by following changes in intrinsic protein fluorescence at
25C. A PiStar-180 stopped-flow fluorimeter (Applied Photophysics,
Leatherhead, United Kingdom) set to an excitation wavelength of
295 nm was used to measure the variation in fluorescence at 320 nm of res-
idue W184 in CTD.
To determine the association kinetics parameters, CTD (1 mMmonomer)
in sodium phosphate buffer, pH 7.4, was fully dissociated and denatured by
addition to GdmHCl to 3 M or higher concentrations in different aliquots.
For each aliquot, association of CTD monomers was initiated by 1:10 dilu-
tion in the same buffer without GdmHCl. At the final protein concentration
(100 mM monomer) in the absence of GdmHCl, >90% of the protein is in
dimeric form (61). The data obtained were fitted to the equation that de-
scribes a second-order reaction from monomer to dimer (62,63):
IðtÞ ¼ If  ðA=ðCtkast þ 1ÞÞ; (6)
where I(t) is the fluorescence intensity at time t, If is the fluorescence inten-
sity at infinite time, A is the amplitude of the process, and kas is the associ-
ation rate constant.
To determine the dissociation kinetics parameters, aliquots of 100 mM
CTD in sodium phosphate buffer, pH 7.4, were used. Dissociation of
CTD dimers was initiated by a 1:10 dilution in 25 mM sodium phosphate
buffer, pH 7.4, containing different concentrations of GdmHCl. At the final
protein concentration (10 mM) most of the protein was in monomeric form.
The data obtained were fitted to the equation that describes a first-order
dissociation reaction from dimer to monomer:
IðtÞ ¼ If þ A expðkdistÞ; (7)
where definitions of terms are the same as for Eq. 6, and I(t) is the fluores-
cence intensity at time t, If is the fluorescence intensity at infinite time, A is
the amplitude of the process and kdis is the dissociation rate constant.
The natural logarithms of the different kas and kdis experimentally ob-
tained using different denaturant concentrations were linearly fitted and
extrapolated to obtain the kas and kdis, respectively, in the absence of
denaturant.NMR spectroscopy
One-dimensional 1H-NMR data were acquired at 25C using an Avance
DRX-500 spectrometer (Bruker, Billerica, MA) equipped with a triple reso-
nance probe and z-pulse field gradients. Processing of spectra was carried
out with the TOPSPIN software. Spectra were acquired with a width of
12 ppm. Water was suppressed with the WATERGATE sequence (64).RESULTS
Spectroscopic analysis of the D177-CTD
monomer and dimer conformations
To biophysically characterize D177-CTD dimerization in
solution, we constructed, expressed, and purified D177-
CTD of the same viral strain (pNL4.3) used for crystallo-
graphic studies (32). The extremely slow interconversion
between monomer and dimer forms allowed their separation
by SEC and individual characterization.
The secondary structure of D177-CTD was probed by far-
ultraviolet (far-UV) CD (Fig. 2 a). The spectra obtained for
monomer and dimer revealed the helical content expected
for folded CTD and were indistinguishable from each other
(Fig. 2 a) and from those of the CTD monomer and dimer
without the deletion (21). Thus, deletion of A177 has no
effect on the secondary structure of the CTD monomer.
The tertiary environment of W184 in D177-CTD mono-
mer and dimer was probed by measuring the intrinsic fluo-
rescence. Fluorescence intensity was slightly reduced in the
dimer relative to the monomer, but in both cases the emis-
sion maximum wavelength was ~350 nm (Fig. 2 b). Addi-
tion of GdmHCl up to 5 M did not increase the
fluorescence intensity (results not shown). The maximum
fluorescence emission wavelength in the nonmutated CTD
monomer was also 350 nm, but was blueshifted to 338 nm
in the nonmutated CTD dimer (21). These results are consis-
tent with the different crystal structures of the side-by-side
CTD dimer (5) and the domain-swapped D177-CTD dimer
(32) (Fig. 1 a): in the former, W184 is buried in the dimer-
ization interface, whereas in the latter, it is exposed to sol-
vent (as in the isolated CTD monomer).
One-dimensional 1H-NMR experiments (Fig.S1 in the
Supporting Material) confirmed the exposure to solvent of
W184 in the D177-CTD dimer in solution. The signal of
the indole proton in the side-by-side CTD dimer was very
broad and appeared at 10.65 ppm. In contrast, the same
signal in the D177-CTD dimer was sharp and appeared at
10.35 ppm, close to the value expected in a random-coil
polymer (10.20 ppm). In addition, comparison of NMR
spectra revealed shifted peaks in the methyl region of the
spectra of the D177-CTD dimer that may correspond to
L188 and L189 methyls (the most up-fielded alkyl groups
in the spectrum). This result indicates that the tertiary envi-
ronment around those residues is also different in both
dimers, again consistent with the crystal structures of the
nonswapped and swapped forms of CTD.Thermodynamic analysis of the D177-CTD
monomer folding equilibrium
A previous study (21) showed that addition of GdmHCl to
the CTD dimer leads to both dimer dissociation into folded
monomers and monomer denaturation in a three-state reac-
tion. However, dimer dissociation into folded monomersBiophysical Journal 108(2) 338–349
FIGURE 2 Spectroscopic and thermodynamic analyses of D177-CTD. (a) Far-UV CD spectra of the D177-CTD monomer (solid line) and dimer (dashed
line). (b) Fluorescence spectra of D177-CTD monomer (solid line) and dimer (dashed line). (c) Chemical denaturation curve of the D177 monomer obtained
by measuring the ellipticity at 222 nm as a function of GdmHCl concentration of D177-CTD monomer (solid circles) or dimer (inverted triangles). (d) Ther-
mal denaturation curve of the D177-CTD monomer. Fitting of data in (c) and (d) is indicated by solid lines. The values obtained for the thermodynamic
parameters are indicated in Table 1. In (a)–(d), 20 mM protein in 25 mM sodium phosphate pH 7.4 at 25C were used. (e) Analytical SEC of D177-CTD
at equilibrium between monomer and dimer, using 500 mM protein in PBS buffer, pH 7.4, and 5 mM DTT.
342 Bocanegra et al.fully exposes the only Trp to solvent (leading to a change in
Trp fluorescence), whereas it does not change the secondary
structure of the protein (as observed by far-UV CD). In turn,
denaturation of the folded monomers leads to no further
exposure of Trp to solvent (no change in Trp fluorescence)
but it does change the secondary structure of the protein
(as measured by far-UV CD). Thus, dimer dissociation
was spectroscopically silent when measuring the ellipticity
signal at 222 nm by CD, whereas monomer unfolding was
spectroscopically silent when measuring the Trp fluores-
cence signal on excitation at 295 nm. As a consequence,
the two steps of the three-state (dissociation and unfolding)
reaction can be thermodynamically (21) and kinetically
analyzed separately as simple two-state reactions.
Like CTD, both monomer and dimer of D177-CTD
showed the same far-UV CD spectrum, and D177-CTD
dissociation was spectroscopically silent using CD. Thus,
far-UV CD made it possible to specifically follow the
folding/unfolding equilibrium of the D177-CTD monomer,
irrespective of which form (monomer or dimer) was used,
in chemical denaturation experiments as carried out for non-
mutated CTD (21).
The unfolding equilibrium data obtained for D177-CTD
in two representative experiments are shown in Fig. 2 c.
They fitted well a two-state unimolecular transition (nativeBiophysical Journal 108(2) 338–349monomer to denatured monomer). The process was fully
reversible and, as expected, independent of protein concen-
tration (Fig. S2). Again as expected, with either monomer or
dimer, the values obtained for the thermodynamic parame-
ters were not significantly different (Table 1). The values ob-
tained for the D177-CTD monomer are also very similar to
those obtained for nonmutated CTD under the same condi-
tions (Table 1). The m-values obtained corresponded to
those calculated (65) for the monomeric structures of
D177-CTD and CTD (2.0 kcal mol1 M1 and 2.2 kcal
mol1 M1, respectively).
The unfolding equilibrium of the D177-CTD monomer
was also analyzed in thermal denaturation experiments fol-
lowed by far-UV-CD. The data obtained in a representative
experiment are shown in Fig. 2 d. These data fitted very well
a two-state unimolecular transition, and the process was
reversible (Fig. S2). The values of the thermodynamic pa-
rameters obtained using Eqs. 1 and 2 were very similar to
those obtained for nonmutated CTD under the same condi-
tions (Table 1).
The above results revealed that D177-CTD and CTD
monomers in solution have the same secondary structure,
solvent exposure of W184, and thermodynamic stability.
Thus, both monomers probably present quite similar struc-
tures in solution (except for a small region around Ala177).
TABLE 1 Thermodynamic parameters of D177-CTD and CTD monomer unfolding, and kinetic and thermodynamic parameters for
dimerization of D177-CTD and CTD
Protein Thermodynamics of folding
DGu
H2O (kcal mol1) m (kcal mol1 M1) [D]50%(M) Tm (C) DHu
Tm (kcal mol1)
D177-CTD 5.15 0.2 1.955 0.07 2.625 0.01 62.75 0.2 38 5 2
CTD 4.45 0.1 1.925 0.04 2.295 0.01 63.15 0.1 45 5 1
Kinetics and thermodynamics of dimerization
kas (M
1 s1) kdis (s
1) kdis/kas (mM)
a Kd (mM)
b
D177-CTD (1.25 0.2)  102 (75 2)  107 c 585 9
(4.25 0.5)  105 d 35005 185 21005 1000
CTD (7.955 0.02)  106 1005 2 12.15 0.1 8.3 5 2.1
Fitting values and errors are indicated.
aEquilibrium constant Kd calculated as the ratio between rate constants.
bEquilibrium constant Kd calculated in equilibrium experiments using SEC.
cRate constant kdis1 corresponding to the slowest dissociation process.
dRate constant kdis2 corresponding to the fastest dissociation process.
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dimerization equilibrium
Solutions of concentrated D177-CTD were left for several
weeks until chemical equilibrium was reached and then sub-
jected to analytical SEC. The chromatograms (Fig. 2 e)
showed two peaks with apparent molecular masses of
13 kDa and 26 kDa. The somewhat increased apparent mo-
lecular masses relative to their true masses (9.5 kDa and
19 kDa) are likely due to the somewhat elongated shape
of the CTD, which is more pronounced in the D177-CTD
dimer. No additional oligomeric forms were significantly
populated, even at very high protein concentration.
We analyzed the D177-CTD dimerization equilibrium at
different pH values (from 5 to 9), ionic strengths (up to
1 M NaCl), and addition of DTT (to 5 mM) at different
(0.3–1 mM) protein concentrations. At the highest protein
concentrations, the maximum proportion of dimer at equi-
librium was 20–25%. Starting with either monomer or
dimer, the same monomer-dimer equilibrium was reestab-
lished after close to one month at 25C. After unfolding
and refolding/reassociation of the monomer by heating to
95C and cooling to 25C, equilibrium was reached at a
much faster rate (minutes) (Fig. S3).
The apparent dissociation equilibrium constant, Kd, was
calculated from the proportion of monomer and dimer at
different total protein concentrations (Eq. 3). In our standard
conditions (PBS buffer, pH 7.4, 5 mM DTT, 25C), the Kd
value obtained was 2.1 5 1.0 mM (Table 1). D177-CTD
of a different HIV-1 strain (BH10), was also prepared and
analyzed. Its Kd was ~5 mM (data not shown), on the
same order as that of strain pNL4.3. By comparison, Kd of
the side-by-side CTD dimer of the same strain under very
similar conditions was 8 mM.Kinetic analysis of D177-CTD dimerization
and dissociation
To determine the association and dissociation rate constants
of the D177-CTD dimer, we again took advantage of theextremely slow monomer-dimer interconversion. Both
forms were separated by SEC and found to be essentially
free of the other form. Isolated monomer (300 mM) and
dimer (20 mM) were allowed to proceed toward equilibrium,
and the dimer/monomer ratio at different times was esti-
mated by SEC. This allowed a direct determination of the
association and dissociation rate constants in the absence
of any denaturing agent (Fig. 3, a and b).
The association kinetics showed a very good fit with Eq.
4, which describes a bimolecular reaction between two
monomers to form a dimer (Fig. 3 a), which in turn yields
the association rate constant (Table 1).
The dissociation kinetics could not be fitted to a single-
exponential equation. However, the data could be very
well fitted to an equation that describes two exponential un-
imolecular reactions (Eq. 5) with similar amplitudes and
rate constants that differ by two orders of magnitude
(Fig. 3 b and Table 1). The corresponding apparent dissoci-
ation equilibrium constants, calculated as the kdis/kas ratio,
were Kd1 ¼ 3.5 mM and Kd2 ¼ 58 mM (Table 1). Thus,
dissociation of domain-swapped D177-CTD may involve
two different reactions. Though further investigation is
required, a simple possibility is that the protein may be pre-
sent in two similarly populated, conformationally noniden-
tical dimeric forms (indistinguishable by SEC); both
dimeric forms could dissociate at different rates to yield
the folded monomeric form. None of these forms corre-
spond to the canonical dimer, as the dissociation rate con-
stant of the latter was several orders of magnitude higher
(see below). The form that dissociates relatively faster
would be predominant, and its kdis/kas ¼ 3.5 mM corre-
sponds fairly well to the Kd ¼2.1 mM calculated from equi-
librium experiments (Table 1). The slightly higher value of
kdis/kas compared to Kd could be due to the fact that for the
D177-CTD kas calculation, we considered the association
process only and assumed dissociation to be negligible. In
fact, the values in Table 1 suggest a significant contribution
of dissociation as the dimer is formed, and the kas value ob-
tained may be somewhat underestimated.Biophysical Journal 108(2) 338–349
FIGURE 3 Kinetic analysis of association and
dissociation of D177-CTD and CTD. (a and b)
D177-CTD association (a) and dissociation
kinetics (b). Errors are <10% of the measured
value. (c and d) CTD association (c) and dissocia-
tion rate constants (d) as a function of denaturant
concentration. Values correspond to the average
of at least six kinetic traces. Fitting of data in
(a)–(d) is indicated by solid lines. Error bars corre-
spond to standard deviations. The values obtained
for the kinetic parameters are indicated in Table 1.
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and dissociation
To compare the association and dissociation kinetics of
D177-CTD with those of the side-by-side CTD dimer, we
also had to determine the kinetic parameters of the latter,
as they had not been obtained previously. CTD monomer
unfolding was spectroscopically silent when Trp fluores-
cence was used as a probe (see above and Mateu (21)).
Thus, only the dissociation and association rate constants
influence the kinetics observed by following the Trp fluores-
cence intensity at 350 nm at different GdmHCl concentra-
tions, and those constants could be directly determined in
stopped-flow experiments (Fig. 3, c and d, and Table 1).
The association reaction was so fast that the initial part of
the reaction was lost in the dead time of the instrument.
However, as expected, the data obtained in repeated exper-
iments fitted well an equation that describes a bimolecular
reaction between two monomers to yield a dimer. Linear
fitting of the ln(kas) values as a function of denaturant con-
centration (Fig. 3 c) and extrapolation to zero denaturant
yielded kas
H2O (Table 1). In this case, the values in Table 1
indicate that the contribution of kdis is negligible. Thus,
the rate constant value obtained should correspond to kas.
The dissociation reaction was also very fast, and again,
although the initial part of the reaction was lost in the
dead time of the instrument, the data obtained in different
experiments fitted well the expected single-exponential
equation that describes a unimolecular dissociation reaction
from dimer to monomers. Linear fitting of the ln(kdis) valuesBiophysical Journal 108(2) 338–349as a function of denaturant concentration (Fig. 3 d) and
extrapolation to zero denaturant yielded kdis
H2O (Table 1).
Because of the relatively high denaturant concentration
and low protein concentration, the contribution of kas to
the experimental data under these conditions should be
negligible, and the value obtained should correspond to kdis.
The apparent dissociation equilibrium constant, Kd,
calculated as the kdis/kas ratio, was 12.1 5 0.1 mM (Table
1), very close to the Kd values obtained in equilibrium ana-
lyses under very similar conditions using analytical centri-
fugation (10 mM (5)) or SEC (8 mM (61)). Thus, loss of
the initial part of the reactions in the dead time of the instru-
ment did not have a significant effect on the estimation of
the rate constants.
To sum up, under the conditions used, side-by-side dimer-
ization of CTD is extremely fast, but the affinity constant is
not high, because dimer dissociation is also very fast. In
contrast, dimerization of D177-CTD is an extremely slow
process, the rate of which can be greatly increased by previ-
ous thermal unfolding of the monomer. The affinity constant
is very low, and it is not even lower because dissociation of
the dimer is also very slow.Mutational analysis of the role of conserved MHR
residues and other interfacial residues in the
thermodynamic stability of the CTD monomer
The above biophysical characterization allowed a molecular
dissection of the relevance of MHR and other CTD residues
Energetics of MHR in HIV Capsid Protein 345structurally involved in the domain-swapped interface (32)
(Fig. 1 c), in terms of both folding and stability of the CTD
monomer and dimerization affinity of D177-CTD. We chose
for mutational analysis six MHR residues (Table 2).
Five of these residues are highly conserved in retroviruses
and participate in hydrophobic contacts and/or hydrogen
bonds between monomers in the domain-swapped dimer,
whereas R154 is less conserved and participates in a few in-
teractions only (Table 2). The side chains of three of these
residues (Q155, F161, and Y164) belong to the primary
interface (sensu stricto), whereas those of three others
(R154, V165, and F168) belong to the secondary interface
in the domain-swapped dimer (Fig. 1 c and Table 2). Only
one other MHR residue (Y169) participates in intermono-
mer interactions in the swapped dimer, but this residue
was not chosen for mutation, as it is less conserved. In addi-
tion, we chose four non-MHR residues (M185, L189, N193,
and N195) involved in the highest numbers of hydrophobic
contacts and/or hydrogen bonds between monomers in the
swapped dimer (Table 2). These four residues belong to
the secondary interface (Fig. 1 c and Table 2).
The parental fusion protein GST-D177-CTD and 7 of the
10 mutants could be expressed, and after cleavage, the iso-
lated domain could be obtained in soluble form. However,
these mutations led to levels of soluble CTD that were
reduced to different extents, and mutations of MHR residues
F168 and N193 greatly favored aggregation. In addition, mu-
tation of any of the three MHR residues at the primary inter-
face led to proteolytic degradation of D177-CTD during
expression of the fusion protein, usually yielding GST only.
In some preparations of these three mutants, a very small
amount of GST-D177-CTD could be obtained initially, butTABLE 2 Mutational analysis of the role of interfacial residues in the
in the affinity of D177-CTD dimerization
Mutation
Location in CTD and
in swapped interfacea % Cb
Interactionsc
D177-CTD CTD Tm (
C
Parent 62.75 0
Q155A MHR Prim 100 1/26/7 1/46/18 unfolde
F161A MHR Prim 71 0/34/25 0/40/32 unfolde
Y164A MHR Prim 100 1/33/16 1/38/19 unfolde
R154A MHR Sec 50 0/5/1 0/3/2 59.25 0
V165A MHR Sec 93 0/12/9 0/5/5 59.65 0
F168A MHR Sec 100 0/30/26 0/33/27 47.05 2
M185A h9 Sec 21 0/20/12 0/6/4 67.15 0
L189A h9 Sec 50 0/7/7 0/4/3 61.15 0
N193A h9 Sec 50 1/9/1 1/8/1 52.25 0
N195A L9-10 Sec 50 1/17/4 1/8/1 56.05 0
Fitting values and errors are indicated. For Kd values, no fitting errors are ap
corresponding to monomer and dimer SEC peaks at equilibrium. The errors betw
and <1 mM for Kd. h9, helix 9; L9-10, loop between helices 9 and 10; Prim, p
aLocation of the original residue.
bPercent conservation of the original residue in retroviruses (66).
cInteractions of the original residue, expressed as number of hydrogen bonds/tota
gram WHATIF (70) and a cutoff distance of 3.5 A˚ (for H-bonds) and 1 A˚ long
dFor N193A, the Kd could not be determined due to the small amounts of solubl
time (weeks) required for equilibrium analysis using SEC.after thrombin digestion, only GST remained (i.e., without
D177-CTD). These observations indicate that these three
CTD mutants are unable to fold under those conditions.
All seven D177-CTD mutants that could be obtained in a
soluble, folded state showed the same minima at 208 and
220 nm as the parent protein D177-CTD by far-UV CD.
They also showed the same maximum around 350 nm in
their fluorescence emission spectrum, although in two of
them (L189A and V165A) minor blue shifts were observed
that could be due to small differences in the tertiary environ-
ment of W184. All CD and fluorescence spectra were super-
imposable on those of the parental D177-CTD except for the
three mutants with the highest tendencies to aggregate, in
which the ellipticity and fluorescence intensity were propor-
tionally reduced at all wavelengths, most likely due to par-
tial aggregation during the analyses (results not shown). The
thermodynamic stability of the seven D177-CTD mutants
that were capable of folding was then determined in thermal
denaturation experiments like that shown in Fig. 2 d (Table
2). Mutation of most residues led to a substantial destabili-
zation of the folded CTD monomer.
Most MHR residues with a high degree of conservation
among retroviruses (66) were found to be important for
CTD folding/stability. These residues include the three res-
idues that had been previously analyzed (21), E159, R167,
and G156, as well as Q155, F161, Y164, V165, and F168
(Table 2). In contrast, MHR residue R154, which is much
less conserved than the others, barely contributed to CTD
stability (Table 2).
It could be argued that the observed disruptive or destabi-
lizing effects of the analyzed mutations on the folding and
stability of the D177-CTD monomer could be influencedrmodynamic stability of theD177-CTD and CTDmonomers and
D177-CTD CTD
) DHu
Tm (kcal mol1) Kd (mM) Tm (C) DHu
Tm (kcal mol1)
.2 385 2 2.1 63.15 0.1 45 5 1
d unfolded
d unfolded
d unfolded
.1 495 3 1.1 62.15 0.6 44 5 3
.1 505 3 1.2 47.95 1.0 27 5 2
.0 315 7 10.9 58.85 0.6 37 5 1
.1 615 4 2.3 56.05 1.0 27 5 8
.1 515 3 2.2 ND ND
.8 515 9 NDd 52.05 5.0 17 5 8
.2 445 7 6.9 ND ND
plicable as these values were directly determined by measuring the areas
een repeated experiments were <2C for Tm, <10 kcal mol
1 for DHu
Tm,
rimary interface; Sec, secondary interface; ND, not determined.
l van der Waals contacts/carbon-carbon contacts, determined using the pro-
er than the sum of van der Waals ratios (for vdW contacts).
e protein obtained and its tendency to aggregate during the long incubation
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mutations of the same six MHR residues, as well as of two of
the four nonMHR residues, in the intact CTD of the same
HIV-1 strain; we then tested for their effects on CTD mono-
mer folding and stability, as described above for D177-CTD
(Table 2). In general, the results were qualitatively similar to
those obtained for D177-CTD: In both cases, mutants
Q155A, F161A, and Y164A led to unfolded protein;
N193A and R154A had a large or small effect, respectively,
on protein stability. V165A, F168A, and M185A, however,
led to quantitatively different destabilizing effects that sug-
gest some local differences in the tertiary structure of the
monomer due to the A177 deletion in D177-CTD.Mutational analysis of the role of conserved MHR
residues and other interfacial residues in the
affinity of D177-CTD dimerization
The effect of mutation of the three conserved MHR residues
at the primary interface on D177-CTD dimerization could
not be tested, because these mutations completely prevented
stable folding of the CTD monomer (see previous section).
However, six D177-CTD mutants could be obtained in
folded, soluble form and their aggregation could be pre-
vented even at the high concentration needed for analysis
of the D177-CTD dimerization equilibrium. These muta-
tions involved two highly conserved MHR residues (V165
and F168), a less conserved MHR residue (R154), and three
non-MHR residues (M185, L189, and N195), all at the sec-
ondary interface in the domain-swapped dimer (Fig. 1 c and
Table 2). The dimerization affinity of these mutants was
determined by SEC (Table 2).
Of the six mutations tested, only F168A and N195A led to
a significant increase in the apparent dissociation equilib-
rium constant, Kd. Thus, only one of the three highly
conserved MHR residues tested (F168) significantly con-
tributes to D177-CTD dimerization. The two other MHR
residues tested (R154A and V165A) are not involved in
dimerization energetics.
In summary, for MHR residues, no correspondence was
found between their conservation in retroviruses and their
contribution to the affinity of D177-CTD dimerization. In
contrast, nearly all highly conserved MHR residues are
involved in the stable folding of the CTDmonomer, whereas
the less conservedMHR residue, R154, makes no significant
contribution.DISCUSSION
Thermodynamic and kinetics of domain swapping
in CTD: comparison with other proteins and
dissection of a domain-swapped interface
D177-CTD crystallizes only as a domain-swapped dimer,
but it could be argued that the dimer it forms in solutionBiophysical Journal 108(2) 338–349is not domain-swapped. A considerable body of evidence,
discussed in this section, clearly indicates that the D177-
CTD dimer in solution is not the canonical CTD dimer
but a domain-swapped dimer. The evidence is largely based
on what has been learned about domain swapping in general
from studies carried out with a number of domain-swapped
dimers (48,49). Despite the wide differences among them in
structure, function, and evolutionary origin, they present
common features that are exclusive of their dimerization
by domain swapping. These include extremely low associa-
tion and dissociation rate constants and a dramatic acceler-
ation of dimerization by heating and cooling (48,49). Such
features are explained because domain swapping usually
requires substantial unfolding of the monomer before
the domain can be swapped (55,58). Dimerization reactions
that do not involve swapping show no such behavior,
because they do not require substantial monomer unfolding.
With the above specific features of domain swapping in
mind, the following evidence clearly supports that the
D177-CTD dimer in solution is domain-swapped. 1) Asso-
ciation and dissociation rate constants are an extremely
low hallmark of domain-swapped dimers. 2) Dimerization
is extremely accelerated (from weeks to minutes) by heating
and cooling, another telling signature of domain swapping,
as discussed above. 3) In the D177-CTD dimer, both in
solution and in crystal form, residues F168 and N195 are
involved in dimerization. 4) In the D177-CTD dimer, both
in solution and in crystal form, W184 is fully exposed to sol-
vent, as indicated by both fluorescence and NMR. 5) NMR
results also suggest that the environment around the L188
and L189 side chains is altered in the D177-CTD dimer in
solution, as would be expected if it is swapped. 6) The
D177-CTD dimer, both in solution and in crystal form,
has a shape that is more elongated than that of the canonical
CTD dimer. All these results taken together provide strong
evidence that D177-CTD forms a noncanonical, domain-
swapped dimer in solution, in agreement with its structure
as determined by x-ray crystallography.
The Kd for the domain-swapped SCAN dimer (the only
known homolog of retroviral CTD) has not been deter-
mined, but no traces of monomer were observed by SEC
at 225 mM (30), which suggests a Kd of <10 mM. Unlike
SCAN, and even with A177 deleted, the Kd obtained for
D177-CTD was as high as 2.1 mM. A similar value was ob-
tained for the domain-swapped p13suc1 dimer (Kd
¼1.8 mM), but this value was for the natural domain;
some deletions in the p13suc1 hinge led to a much lower
Kd (55). Thus, although the CTD of HIV-1 CA can dimerize
through domain swapping, its propensity to do so is mar-
ginal compared to other domain-swapping proteins.
As for other domain-swapped dimers, the extremely
slow association and dissociation rates of D177-CTD and
the dramatic reduction in time required to reach equilib-
rium indicates the existence of a large kinetic barrier for
dimerization. In the CTD monomer, many conserved
Energetics of MHR in HIV Capsid Protein 347residues in the region to be swapped have numerous inter-
actions with the rest of the polypeptide, and our thermody-
namic analysis showed that these residues are critically
involved in stabilizing the monomer. Domain swapping re-
quires disruption of all these energetically important inter-
actions. These observations suggest that the transition state
for interconversion between D177-CTD monomer and
swapped dimer may be a substantially unfolded form of
the protein.
Mutational analyses allowed the identification of a few
CTD residues at the swapped interface that are energetically
important for folding and stability and/or dimerization by
swapping. Three residues (Q155, F161, and Y164) involved
in multiple intersubunit interactions at the primary interface
were critical for CTD monomer folding and stability. Of the
six tested residues at the secondary interface in D177-CTD,
only the two that are involved in a substantial number of in-
teractions in both monomer and swapped dimer (F168 and
N195) significantly favor the domain-swapped dimer rela-
tive to the free monomer.
To sum up, the D177-CTD domain-swapped interface in-
cludes several residues that are required for folding and sta-
bility of the monomer. The strong interactions these residues
establish in the monomer may dramatically slow down
dimerization by domain swapping. A few residues at the
swapped interface define a limited number of energetic hot-
spots of D177-CTD dimerization.Is CTD dimerization by domain swapping
involved in HIV-1 capsid assembly, and could it
provide a novel target for antiviral intervention?
Although MHR swapping does not appear to be present in
assembled retrovirus capsids (8,13,14), it has been sug-
gested that it could still transiently occur, either on- or
off-pathway, during the assembly reaction. This possibility
may be pondered in the light of the results presented here
on the thermodynamics and kinetics of D177-CTD dimer-
ization by domain swapping in solution.
First, even after engineering a deletion that greatly fa-
vors swapping, the Kd is >2 mM. This corresponds to a
marginal intrinsic propensity compared to those observed
for the homologous SCAN domain and other domain-
swapping proteins. A most serious difficulty for domain
swapping in CTD is that several residues in the motif
to be swapped (the MHR) are heavily involved in energet-
ically important intramonomer interactions that must be
disrupted before the swapped dimer can be formed. This
leads to a very high kinetic barrier and to extremely slow
association and dissociation. It has been suggested that
the process could be speeded up in vivo by coupling with
some other binding event, such as association of the nucle-
ocapsid domain in Gag with the viral RNA (67), and
macromolecular crowding effects could also help (68,69).
However, the observed kas would need to increase by asmany as five or more orders of magnitude to complete
the process in seconds or minutes.
A strong argument for a transient role of MHR swapping
during HIV-1 assembly could still be made if there were a
correspondence between evolutionary conservation of
MHR residues in retroviruses and net energetic contribution
to D177-CTD dimerization by domain swapping (32,67).
However, no such correspondence was found in our muta-
tional analysis of MHR residues.
In summary, the above observations do not provide sup-
port for even transient MHR swapping during HIV capsid
assembly. In fact, the quite marginal propensity of the con-
formationally plastic CTD to dimerize by domain swapping
could be an evolutionary remnant of a reaction that at pre-
sent may be biologically relevant only in some homologous
protein (e.g., the mammalian SCAN domain). However, it
cannot be excluded that a combination of structural context,
nucleation, coupled reactions, and macromolecular crowd-
ing effects could lead to transient MHR swapping during
HIV capsid assembly in the cell.
In our opinion, even though MHR swapping may not
occur during HIV morphogenesis, it definitely offers a novel
approach for anti-HIV intervention. The exclusive presence
of a secondary interface in the domain-swapped dimer, and
our energetic dissection of the swapped interface, may facil-
itate the design of compounds capable of specific binding to
the swapped dimer. Such compounds could promote MHR-
swapping in Gag and/or free CA by stabilizing the second-
ary interface, thus inhibiting HIV capsid assembly and viral
infection by conformational trapping.A critical role of conserved MHR residues in
folding and stability of the CTD monomer may
help to explain the multiple biological effects of
the MHR in retrovirus infection
The nonswapped MHR motif may participate in CTD-CTD
recognition in the immature retroviral capsid (8), which pro-
vides a simple structural basis for the detrimental effects in
immature capsid assembly caused by mutations in the
MHR. Still, one might wonder why the MHR is so conspic-
uously conserved relative to other structural elements that
are critically involved in intersubunit recognition in the
immature (or mature) capsid. Moreover, the MHR also has
been found to be functionally involved in other steps of
the viral cycle.
In this study, we found that all eight highly conserved
MHR residues tested (five in this study and three others dur-
ing an early thermodynamic analysis of the side-by-side
CTD dimer (21)) are required for folding and stability of
the CTD monomer. Also, we detected a correlation between
their conservation and their importance for folding and sta-
bility. These effects were rather unexpected. First, they were
observed for nearly half of the residues in a single small (20-
amino-acid) structural element within a protein domain.Biophysical Journal 108(2) 338–349
348 Bocanegra et al.Second, most of those eight conserved MHR residues are
not in the protein hydrophobic core; in fact, they have polar,
solvent-exposed side chains. As expected, alanine mutation
of several other polar and apolar residues in CTD, including
those at the side-by-side dimerization interface and some
other buried residues, generally had no such dramatic effects
on monomer folding whatsoever (61). To our knowledge,
this is a rather unique situation in proteins. The MHR ap-
pears to constitute a self-structured subdomain with a crit-
ical role in folding and stability of the CTD of the
retroviral capsid protein.
Based on the above observations we propose that in addi-
tion to the detected direct functional roles of the MHR in ret-
roviruses, the unusually important role of many MHR
residues in CTD folding helps to explain their high conser-
vation and biological importance. Mutations in the MHR
impair CTD folding and facilitate degradation or aggrega-
tion, reducing the availability of correctly folded Gag and
CA, not only for immature capsid assembly but also in other
stages of the retroviral cycle in which these proteins are
involved.SUPPORTING MATERIAL
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